Mathes Company, Inc. Bristol Myers Squibb CO Transaction History

Mathes Company, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $412,634 - $457,253	-7,185 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $30,699 - $35,890	560 Added 8.45%	7,185 $422,000
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $60,320 - $87,659	-1,300 Reduced 16.4%	6,625 $369,000
Q4 2019 Jan 30, 2020	SELL	$49.21 - $64.19 $538,062 - $701,853	-10,934 Reduced 57.98%	7,925 $509,000
Q2 2019 Jul 29, 2019	BUY	$44.62 - $49.34 $575,598 - $636,486	12,900 Added 216.48%	18,859 $855,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $45,120 - $53,800	1,000 Added 20.17%	5,959 $284,000
Q3 2017 Oct 20, 2017	BUY	$55.23 - $63.74 $273,885 - $316,086	4,959	4,959 $316,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Mathes Company, Inc. with notifications on news.